149,992 members

Skip to content. | Skip to navigation


Hormone therapy aids prostate cancer survival


Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.

Hormone therapy aids prostate cancer survival

The Daily Express reports that a “new treatment for prostate cancer has cut the risk of dying by half”. It said that “six months of the hormone therapy……is all that is needed”, and the benefits continue for 10 years.

The trial in question did not look at androgen deprivation therapy (ADT) alone. It provided either three or six months of ADT before and around the time that the men received radiotherapy (a schedule of delivery referred to as neoadjuvant therapy), and compared this with radiotherapy alone. It found that six months of neoadjuvant ADT reduced the chances of men dying from prostate cancer over 10 years of follow-up, but three months of neoadjuvant ADT only significantly improved some outcomes, but not deaths from prostate cancer. More …..